Site Selection Group, LLC – Trademark Portfolio
Entity Type: 16
Site Selection Group, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 7 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include INCENTRAK, LABORCAST, COMPETENOW, and SITE SELECTION GROUP. The owner is based in Dallas, TX.
8300 Douglas Avenue, Suite 700
Dallas, TX 75205
Showing of trademarks Trademarks
Trademark Classifications
Site Selection Group, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Site Selection Group, LLC have?
Site Selection Group, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned, 1 cancelled.
What trademark classes does Site Selection Group, LLC file in?
Site Selection Group, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Site Selection Group, LLC's most well-known trademarks?
Site Selection Group, LLC's registered trademark portfolio includes well-known marks such as INCENTRAK, LABORCAST, COMPETENOW, and SITE SELECTION GROUP. These are among 5 currently registered trademarks in the portfolio.
What is Site Selection Group, LLC's trademark registration success rate?
Site Selection Group, LLC has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.